- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07603973
Effect of an Information- and Self-management App for People With Knee Osteoarthritis (OA-AID)
The primary aim of the trial is to assess if an information- and self-management app provided in the period between referral and consultation in specialist healthcare can improve knowledge about osteoarthritis and decision quality during consultation in patients with knee osteoarthritis.
204 patients will be randomized to either being on the waiting list for consultation, accessing publically available information about osteoarthritis (control group) or getting access to an 8-week information- and self-management intervention delivered through the Genus app prior to consultation.
Pasients with answer questionnaires at baseline, 4 weeks (intervention group only), 8 weeks, post consultation and 1 and 2 years after consultation.
The Genus app contains information videos, exercise videos, quizzes, feedback and questionnaires provided in a progressive order over an 8 week period.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Anne Therese Tveter, PhD
- Numéro de téléphone: +4791115550
- E-mail: a.t.tveter@medisin.uio.no
Lieux d'étude
-
-
Oslo
-
Oslo, Oslo, Norvège, 0317
- Recrutement
- Diakonhjemmet Hospital
-
Contact:
- Anne Therese Tveter, PhD
- Numéro de téléphone: +4791115550
- E-mail: a.t.tveter@medisin.uio.no
-
Contact:
- Tuva Moseng, PhD
- Numéro de téléphone: +4747306697
- E-mail: tuva.moseng@diakonsyk.no
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Men and women > 50 years referred to specialist healthcare for knee OA management
Exclusion Criteria:
- Received joint replacement or are under consideration for revision in the referred joint
- Have undergone joint replacement surgery in opposite knee
- Have uncontrolled serious comorbidities
- Have cognitive deficits
- Are seeking care for recent knee trauma conditions (less than 6 months after trauma) or mainly psoriatic/rheumatoid arthritis
- Unable to understand Norwegian
- Do not possess a smartphone
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Intervention group
Getting access to an information- and self-management app in the waiting period from referral to consultation in specialist healthcare
|
An information- and self-management intervention delivered through the Genus app, including information videos, exercise videos, questionnaires, quizzes and feedback provided over an 8 week period prior to consultation in specialist healthcare
|
|
Comparateur actif: Control group
Getting access to publicly available information in the waiting period from referral to consultation in specialist healthcare
|
Information on where to access publically available information about knee osteoarthritis
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Knee Osteoathritis Knowlegde Scale (KOAKS)
Délai: Baseline, 8 weeks, approx. 2-4 months after baseline (1 day after consultation (post consultation))
|
11 statements about osteoarthritis and treatment options, answered on a 5-point scale from 1 (=true) to 5 (=not true), summed up to a scale from 11 to 55
|
Baseline, 8 weeks, approx. 2-4 months after baseline (1 day after consultation (post consultation))
|
|
Decision Conflict Scale (DCS)
Délai: approx. 2-4 months after baseline (1 day after consultation (post consultation))
|
16 statements with 5 response categories about the patients uncertainty with treatment options.
The total score range from 0 (no decisional conflict) to 100 (extreme decisional conflict).
The DCS also has five subscales (all 0-100): 1) uncertainty, 2) informed, 3) values clarity, 4) support, and 5) effective decision.
|
approx. 2-4 months after baseline (1 day after consultation (post consultation))
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Concordance between preferences and treatment decision
Délai: approx. 2-4 months after baseline (1 day after consultation (post consultation))
|
Measured with one qustion form the Decision Conflict Scale (DSC), 5 response options.
|
approx. 2-4 months after baseline (1 day after consultation (post consultation))
|
|
Decisional quality
Délai: approx. 2-4 months after baseline (1 day after consultation (post consultation))
|
Measured with section 3 (decision process scale) in the Decision Quality Index for Knee Osteoarthritis (K-DQI) which consists of 5 questions.
Four of these questions are summed to a 0-4 score with higher score indicating more shared decision-making.
|
approx. 2-4 months after baseline (1 day after consultation (post consultation))
|
|
Level of shared decision-making
Délai: approx. 2-4 months after baseline (1 day after consultation (post consultation))
|
Mesured with the CollaboRATE questionnaire, comprising 3 questions measured on a 0-9 scale, with a higher score indicating better experience.
Scores are calculated using the top score method indicating the percentage of patients scoring top score for all three questions, or
|
approx. 2-4 months after baseline (1 day after consultation (post consultation))
|
|
Satisfaction with treatment choice
Délai: approx. 2-4 months after baseline (1 day after consultation (post consultation))
|
Measured on a numeric rating scale (0-10, with higher score indicating more satisfaction)
|
approx. 2-4 months after baseline (1 day after consultation (post consultation))
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Motivation for exercise
Délai: Baseline, 4 weeks (only intervention group), 8 weeks
|
Measured on a numeric rating scale from 0 to 10 with higher score indicating higher motivation
|
Baseline, 4 weeks (only intervention group), 8 weeks
|
|
Motivation for surgery
Délai: Baseline, 4 weeks (only intervention group), 8 weeks
|
Measured on a numeric rating scale from 0 to 10 with higher score indicating higher motivation
|
Baseline, 4 weeks (only intervention group), 8 weeks
|
|
Assessment of knee-related pain
Délai: Baseline, 4 weeks (only intervention group), 8 weeks, 1 and 2 years
|
Measured with the Knee Injury and Osteoarthritis Outcome Score (pain section), comprising 9 questions scored on a 5-point scale and calculated to a 0-100 score with higher score indicating less pain
|
Baseline, 4 weeks (only intervention group), 8 weeks, 1 and 2 years
|
|
Assessment of knee-related function
Délai: Baseline, 4 weeks (only intervention group), 8 weeks, 1 and 2 years
|
Measured with the Knee Injury and Osteoarthritis Outcome Score (function section), comprising 17 questions scored on a 5-point scale and calculated to a 0-100 score with higher score indicating less pain
|
Baseline, 4 weeks (only intervention group), 8 weeks, 1 and 2 years
|
|
Assessment of knee-related quality of life
Délai: Baseline, 4 weeks (only intervention group), 8 weeks, 1 and 2 years
|
Measured with the Knee Injury and Osteoarthritis Outcome Score (quality of life section), comprising 4 questions scored on a 5-point scale and calculated to a 0-100 score with higher score indicating less pain
|
Baseline, 4 weeks (only intervention group), 8 weeks, 1 and 2 years
|
|
Health-related quality of life
Délai: Baseline, 1 and 2 years
|
Mesured with EQ-5D-5L, comprising 5 questions with 5 response options.
Summed to an utility index from 1 to 0, with 1 being best health-related quality of life.
Additionally a visual analog scale from 0 to 100 with 100 indicating best health.
|
Baseline, 1 and 2 years
|
|
Level of shared decision-making therapist
Délai: approx. 2-4 months after baseline (1 day after consultation (post consultation))
|
Measured with 7 statements from the MAPPIN'SDM Therapist, measured on a 5-point scale
|
approx. 2-4 months after baseline (1 day after consultation (post consultation))
|
|
Preferred decision-making role
Délai: approx. 2-4 months after baseline (1 day after consultation (post consultation))
|
Measured with the Control Preference Scale, comprising a question with 5 statements about roles, corresponding to active role, collaborative role and passive role
|
approx. 2-4 months after baseline (1 day after consultation (post consultation))
|
|
Illness perception
Délai: Baseline, 8 weeks
|
Measured with the Brief Illness Perception Questionnaire (B-IPQ) comprising 8 questions scored on a 0-10 scale, summed to a 0 to 80 score with higher score indicating poorer illness perception
|
Baseline, 8 weeks
|
|
Pain self-efficacy
Délai: Baseline, 8 weeks
|
Measured with the Pain Self-Efficacy Questionnaire (PSEQ-2) comprising 2 questions about pain self-efficacy, answered on a 0 (not at all confident) to 6 (completely confident) scale.
|
Baseline, 8 weeks
|
|
Pain catastrophizing
Délai: Baseline, 8 weeks
|
Measured with one question about consern about pain, measured on a 0 (not at all) to 4 (all the time) scale.
|
Baseline, 8 weeks
|
|
Pain intensity
Délai: Baseline, 8 weeks
|
Measured with four questions from the Brief Pain Inventory, assessed on numeric rating scales from 0 (no pain) to 10 (worst possible pain).
|
Baseline, 8 weeks
|
|
Pain intensity now
Délai: Baseline, 4 weeks (only intervention group), 8 weeks, 1 and 2 years
|
Measured with one question about pain intensity now on a numeric rating scale from 0 (no pain) to 10 (worst possible pain).
|
Baseline, 4 weeks (only intervention group), 8 weeks, 1 and 2 years
|
|
Disease activity
Délai: Baseline, 8 weeks, 1 and 2 years
|
Measured with a numeric rating scale from 0 (no disease activity) to 10 (worst disease activity)
|
Baseline, 8 weeks, 1 and 2 years
|
|
Fatigue
Délai: Baseline, 8 weeks, 1 and 2 years
|
Measured on a numeric rating scale from 0 (no fatigue) to 10 (worst possible fatigue)
|
Baseline, 8 weeks, 1 and 2 years
|
|
Importance of treatment options
Délai: Baseline, 8 weeks
|
Measured with five questions from Dicision Quality Index for Knee Osteoarthritis (section 1).
Assessed on numeric rating scales from 0 (not at all important) to 10 (extremely important)
|
Baseline, 8 weeks
|
|
Preferred treatment
Délai: Baseline, 8 weeks
|
Measured with a question about if they prefer surgery or non-surgical treatment
|
Baseline, 8 weeks
|
|
Health literacy
Délai: Baseline
|
Measured with the HLS19-Q12 comprising 12 questions about health literacy answered on a 4-point likert scale from 1 (very difficult) to 4 (very easy).
Calculated as percentage (0-100) of items with valid responses that were answered with very easy or easy
|
Baseline
|
|
Self-efficacy of digital solutions
Délai: Baseline
|
Measured with six questions about the self-efficacy of using different digital solutions (mobile phone, tablet, computer, apps, identification portal, helsenorge.no),
assessed on a 6-point scale from never tried to manage very well
|
Baseline
|
|
Previous treatment
Délai: Baseline
|
Assessment of previous treatment, answered with yes/no on questions related to previous physiotherapy treatment, previous osteoarthritis school,
|
Baseline
|
|
Health problems impact on daily living
Délai: Baseline, 8 weeks, 1 and 2 years
|
Measured with one question from the Work Productivity and Activity Impairment questionnaire (WPAI) (question 6), anwered on a numeric rating scale from 0 (no effect on daily activities) to 10 (completely prevent from doing daily activities)
|
Baseline, 8 weeks, 1 and 2 years
|
|
Decision regret
Délai: approx. 2-4 months after baseline (1 day after consultation (post consultation))
|
Measured with item 2 from the Decision regret scale, answered on a 5-point scale from totally agree to totally disagree
|
approx. 2-4 months after baseline (1 day after consultation (post consultation))
|
|
Use of pain medication
Délai: Baseline, 8 weeks, 1 and 2 years
|
Assessed with an open-ended question about the use of pain medication last three months (type and dosage)
|
Baseline, 8 weeks, 1 and 2 years
|
|
Demographics
Délai: Baseline
|
Measured with questions about gender, age, education level, working status, smoking, living arrangements, sosioeconomic status, and support
|
Baseline
|
|
Antropometrics
Délai: Baseline
|
Measured as self-reported hight and weight
|
Baseline
|
|
Joint-spesific information
Délai: Baseline
|
Measured with questions about most trouble some knee, duration of complaints, other joints with complaints
|
Baseline
|
|
Exercise level
Délai: Baseline, 8 weeks, 1 and 2 years
|
Measured with one question about exercise level answered on a 5-point scale from do not exercise to exercise 3 or more times per week
|
Baseline, 8 weeks, 1 and 2 years
|
|
Comorbidities
Délai: Baseline
|
Assessed with 15 questions about the presens of different diseases (yes/no)
|
Baseline
|
|
Usability of the app
Délai: 8 weeks (only intervention group)
|
Measured with System Usability Scale (SUS) comprising 10 statements answered on a 5-point scale from strongly disagree to strongly agree, converted to a 0 to 100 score with higher score indicating better usability
|
8 weeks (only intervention group)
|
|
Satisfaction with the app
Délai: 8 weeks (only the intervention group)
|
Measured with two questions about the satisfaction with the information videos and exercise videos in the app, answered on numeric rating scales from 0 (not statisfied) to 10 (very satisfied)
|
8 weeks (only the intervention group)
|
|
Suitability of the app
Délai: 8 weeks (only the intervention group)
|
Measured with two questions about the suitability of providing information and exercises through an app, answered on numeric rating scales from 0 (not suitable) to 10 (very suitable)
|
8 weeks (only the intervention group)
|
|
Surgical treatment
Délai: 1 and 2 years
|
Measured with a question about whether the patient has undergone surgical treatment (yes/no) and for those answering yes; five questions about the improvement/satisfaction with the surgical treatment, measured on a 5-point scale from very satisfied to very dissatisfied
|
1 and 2 years
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Maladies musculo-squelettiques
- Maladies du cerveau
- Maladies du système nerveux central
- Maladies du système nerveux
- Les troubles mentaux
- Arthrite
- Maladies articulaires
- Maladies rhumatismales
- Troubles neurocognitifs
- Démence
- Tauopathies
- Maladies neurodégénératives
- Arthrose
- Maladie d'Alzheimer
- Arthrose, Genou
Autres numéros d'identification d'étude
- DS-00926
- 938916 (Autre identifiant: Regional committees for medical and health research ethics (REK))
- CIV-25-08-053975 (Autre identifiant: Eudamed CIV ID)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .